How Retatrutide Works and Why Gastrointestinal Symptoms Occur Retatrutide is an investigational triple receptor agonist that activates GLP-1, GIP, and glucagon receptors
Trevogrumab (REGN1033) is an antibody that binds to multiple forms of MSTN with high affinity and specificity, while avoiding closely related proteins such as GDF11 and activins, which also signal through activin type II receptors.[75] Another antibody that targets pro-MSTN and the latent form to inhibit the release of active MSTN is apitegromab (SRK-015).[76] The mature form of MSTN shares high similarity with other closely related TGF- family members, including GDF11, and activin receptors can bind a variety of ligands.[72] Therefore, inhibitors that target only mature MSTN or activin receptors may lead to undesirable off-target effects, as highlighted earlier
10.3389/fimmu.2015.00636 16
Retrieved October 19, 2014
"About the Trump, Eli Lilly, Novo Nordisk deals on GLP-1 prices." ncpa.org Axios
